全球难民癌症负担:系统性审查和元分析
Fantu Mamo Aragaw1,2, Angela Dawson1, Andrew Hayen1
1School of Public Health, Faculty of Health, University of Technology Sydney, Ultimo, New South Wales, Australia.
Journal of migration and health
|October 13, 2025
概括
由于累积暴露,难民面临显著的癌症风险. 这次审查发现了显著的癌症负担,包括难民人群中与非难民人群相比,宫癌和肝癌的发病率更高.
科学领域:
- 流行病学 流行病学
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 难民经历独特的癌症风险从他们的起源,迁移,和主机环境.
- 了解难民群体癌症的流行病学负担对于有针对性的干预至关重要.
研究的目的:
- 系统地综合难民中总体癌症和特定地点癌症的全球流行病学负担.
- 确定难民人口中常见的癌症类型和发病率,流行率和死亡率的差异.
主要方法:
- 在OVID (Medline,Embase),CINAHL和Scopus数据库中进行了系统的文献搜索.
- 来自29项研究 (N=561,850名难民) 的数据使用随机效应模型进行了选和分析.
- 使用R软件估计了特定部位癌症的聚合比例.
主要成果:
- 乳腺癌是最常见的 (25.4%),其次是白血病 (16.9%),肺癌 (4.8%) 和中枢神经系统癌症 (7.0%).
- 与非难民人口相比,难民妇女的宫癌发病率更高,难民男性的肝癌死亡率更高.
- 包含的研究主要关注来自叙利亚和伊拉克的难民,他们在12个国家接受.
结论:
- 难民中存在相当大的癌症负担,患子宫癌和肝癌等特定癌症的风险增加.
- 有限的证据需要进一步的研究,以充分了解这一脆弱群体的癌症流行病学.
- 有针对性的跨学科倡议对于改善难民癌症护理连续性至关重要.
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
406
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
406
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K


